Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study By Guilherme GuainJune 30, 2022
An Investigation Of The Effects Of Curcumin On Anxiety And Depression In Obese Individuals: A Randomized Controlled Trial By Guilherme GuainJune 30, 2022
Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study By Guilherme GuainJune 30, 2022
Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder By Guilherme GuainJune 30, 2022
A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression By Guilherme GuainJune 30, 2022
An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women By Guilherme GuainJune 30, 2022
Open study of creatine monohydrate in treatment-resistant posttraumatic stress disorder. By Guilherme GuainJune 30, 2022
Cognitive effects of creatine monohydrate adjunctive therapy in patients with bipolar depression: Results from a randomized, double-blind, placebo-controlled trial By Guilherme GuainJune 30, 2022
Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study By Guilherme GuainJune 30, 2022
